| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |